Market Cap: $655.42M
LI
Lexicon Pharmaceuticals, Inc.
LXRX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $655.42M
Lexicon Pharmaceuticals Shows Commitment to Innovation Amid Financial Challenges In its recent Q4 earnings report, Lexicon Pharmaceuticals outlines significant advancements in its pipeline amid ongoin…
Earnings Report Anticipation Shifts Focus to Lexicon Pharmaceuticals’ Pipeline Developments Lexicon Pharmaceuticals stands poised to release its quarterly earnings report on March 5, 2026, a key event…
Lexicon Pharmaceuticals Gears Up for Key Earnings Report Amidst Pipeline Developments Lexicon Pharmaceuticals, a biopharmaceutical company focused on advancing innovative therapies, is set to release…
Lexicon Pharmaceuticals Gears Up for Key Earnings Report Amid Strategic Developments Lexicon Pharmaceuticals is on the cusp of unveiling its latest quarterly earnings report, scheduled for March 5, 20…
Empowering Myasthenia Gravis Patients: The Launch of the MG Lexicon The Myasthenia Gravis Foundation of America (MGFA) has recently unveiled the MG Lexicon, a groundbreaking digital resource tailored…
### Empowering Patients: The Launch of the MG Lexicon The Myasthenia Gravis Foundation of America (MGFA) recently introduces the MG Lexicon, a pioneering digital resource aimed at enhancing communicat…
Lexicon Pharmaceuticals Advances in Rare Disease Research Lexicon Pharmaceuticals focuses on developing innovative treatments for rare diseases, particularly through its novel drug candidates. Recentl…
Lexicon Pharmaceuticals Advances in Rare Disease Treatments Amid Market Optimism Lexicon Pharmaceuticals is making strides in the development of innovative treatments for rare diseases, particularly f…
Lexicon Pharmaceuticals: Advancing Rare Disease Treatment Amid Market Uncertainty Lexicon Pharmaceuticals is at the forefront of developing innovative therapies for rare genetic disorders, which posit…
Lexicon Pharmaceuticals Advances in Rare Disease Research Amid Market Volatility Lexicon Pharmaceuticals continues to make significant strides in the field of rare disease research, particularly with…
Lexicon Pharmaceuticals: Innovation in Rare Disease Management Lexicon Pharmaceuticals stands at the forefront of advancing therapies for rare diseases, with a focus on precision medicine and genetic…
Lexicon Pharmaceuticals: Advancements in Rare Disease Therapy Lexicon Pharmaceuticals is currently at a pivotal moment in its development of therapies for rare diseases, particularly in the area of ge…
Lexicon Pharmaceuticals: Advancements in Rare Disease Treatments Lexicon Pharmaceuticals continues to position itself as a leader in the development of innovative therapies for rare diseases, particul…
Lexicon Pharmaceuticals: Advancements in Drug Development and Strategic Focus Lexicon Pharmaceuticals is currently at the forefront of developing innovative therapies targeting rare diseases and metab…
Lexicon Bank Launches New SBA Division to Empower Small Businesses Lexicon Bank is making a significant stride in the small business sector by launching its new Small Business Administration (SBA) Div…
Lexicon Bank Launches SBA Division to Bolster Small Business Lending Lexicon Bank makes a significant move in enhancing its small business lending capabilities by introducing the new Lexicon Bank SBA…
Lexicon Pharmaceuticals Strengthens Position in Device Repair Sector with Apple ASP Designation Lexicon Tech Solutions, a prominent player in K–12 device repair and lifecycle management, announces its…
Lexicon Pharmaceuticals Strengthens Position in Device Management with Apple ASP Designation In a significant development for educational technology, Lexicon Tech Solutions, a leading player in K–12 d…
Lexicon Pharmaceuticals Expands Service Capabilities with Apple Partnership Lexicon Pharmaceuticals announces a significant development with its recent designation as an Authorized Service Provider (A…
Sotagliflozin: Pioneering Cardiovascular Benefits in Diabetes and Kidney Disease Treatment Heart health remains a critical concern as new research highlights the cardiovascular advantages of sotaglifl…
Sotagliflozin: A Breakthrough in Cardiovascular Care for Diabetic Patients As heart health continues to be a pressing concern, particularly for individuals with diabetes and chronic kidney disease, Le…